Target Name: ZNF674-AS1
NCBI ID: G401588
Review Report on ZNF674-AS1 Target / Biomarker Content of Review Report on ZNF674-AS1 Target / Biomarker
ZNF674-AS1
Other Name(s): ZNF674 antisense RNA 1 (head to head)

ZNF674-AS1: A Potential Drug Target and Biomarker

ZNF674-AS1, also known as ZNF674 antisense RNA 1 (head to head), is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. ZNF674-AS1 is a highly conserved gene that is located on chromosome 6p12.3 and has been shown to play a role in various cellular processes, including cell growth, survival, and transcriptional regulation.

The discovery of ZNF674-AS1 as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for various diseases. ZNF674-AS1 has been shown to be involved in a variety of biological processes, including cell proliferation, apoptosis, angiogenesis, and inflammation. Therefore, targeting ZNF674-AS1 with small molecules or other therapeutic approaches may provide new insights into the mechanisms of these processes and may lead to the development of new treatments.

Targeting ZNF674-AS1

ZNF674-AS1 is a protein that is expressed in various tissues and has been shown to play a role in various cellular processes, including cell growth, apoptosis, and angiogenesis. ZNF674-AS1 has been shown to be involved in the regulation of cell proliferation, cell survival, and cellular signaling pathways.

The ZNF674-AS1 gene has four exons, which encode a protein that is 21 kilobases (kb) in length. ZNF674-AS1 has been shown to have a complex structure, with a unique alternate exon pattern that has been identified as a potential drug target.

The alternate exon pattern of ZNF674-AS1 has been shown to be involved in various cellular processes, including cell growth, apoptosis, and angiogenesis. ZNF674-AS1 has been shown to be involved in the regulation of cell proliferation, cell survival, and cellular signaling pathways.

ZNF674-AS1 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. ZNF674-AS1 has been shown to be involved in the regulation of vascular endothelial cell (VEC) proliferation and angiogenesis, which is the process by which new blood vessels are formed.

In addition to its involvement in angiogenesis, ZNF674-AS1 has also been shown to be involved in the regulation of cell apoptosis. Apoptosis is a natural process that is involved in the regulation of cell life cycle, and it is regulated by various signaling pathways, including the TGF-β pathway.

The TGF-β pathway is a well-established signaling pathway that is involved in the regulation of cellular processes, including cell growth, apoptosis, and angiogenesis. ZNF674-AS1 has been shown to be involved in the regulation of TGF-β signaling pathway, which is the primary signaling pathway that regulates cell growth, apoptosis, and angiogenesis.

In conclusion, ZNF674-AS1 is a non-coding RNA molecule that has been shown to play a role in various cellular processes, including cell growth, apoptosis, angiogenesis, and TGF-β signaling pathway. The alternate exon pattern of ZNF674-AS1 has been shown to be involved in these processes and has potential as a drug target or biomarker. Further studies are needed to determine the mechanisms of ZNF674-AS1 and its potential as a drug target or biomarker.

Protein Name: ZNF674 Antisense RNA 1 (head To Head)

The "ZNF674-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF674-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791